United States Government Publishing Office publisher pbl distributor dst United States National Archives and Records Administration Office of the Federal Register author aut Government Organization text government publication eng FR Regulatory Information 2017_register executive 2017-04-22 article Notices D09002ee1c7f1c8f2 D09002ee1c7f1c96e United States Department of Health and Human Services originator org United States Government Agency or Subagency United States Food and Drug Administration originator org United States Government Agency or Subagency The Food and Drug Administration's (FDA or Agency) Center for Drug Evaluation and Research, Professional Affairs and Stakeholder Engagement Staff (PASES), is hosting a 1-day public symposium entitled "Safe Use Symposium: A Focus on Reducing Preventable Harm From Drugs in the Outpatient Setting." The purpose of this symposium is to discuss sources of preventable harm from drugs in the outpatient setting and to stimulate the exchange of ideas among thought leaders on interventions to reduce preventable harms and how these interventions can be studied. 82 FR 18910 https://www.govinfo.gov/app/details/FR-2017-04-24/2017-08182 2017-08182 fr24ap17-45 4164-01-P Docket No. FDA-2017-N-0001 https://www.govinfo.gov/app/details/FR-2017-04-24/2017-08182 https://www.govinfo.gov/content/pkg/FR-2017-04-24/html/2017-08182.htm https://www.govinfo.gov/content/pkg/FR-2017-04-24/pdf/2017-08182.pdf 1 p. 18910 18910 82 FR 18910 Safe Use Symposium: A Focus on Reducing Preventable Harm From Drugs in the Outpatient Setting; Federal Register Vol. 82, Issue NOTICE 2017-08182 DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Docket No. FDA-2017-N-0001 4164-01-P 2017-08182 Notice of public symposium.

The Food and Drug Administration's (FDA or Agency) Center for Drug Evaluation and Research, Professional Affairs and Stakeholder Engagement Staff (PASES), is hosting a 1-day public symposium entitled "Safe Use Symposium: A Focus on Reducing Preventable Harm From Drugs in the Outpatient Setting." The purpose of this symposium is to discuss sources of preventable harm from drugs in the outpatient setting and to stimulate the exchange of ideas among thought leaders on interventions to reduce preventable harms and how these interventions can be studied.

The public symposium will be held on June 15, 2017, from 8 a.m. to 4 p.m. Christine Lee, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Silver Spring, MD 20993-0002, 240-402-4228, email: CDERSafeUseInitiative@fda.hhs.gov. Meetings: Safe Use Symposium: A Focus on Reducing Preventable Harm from Drugs in the Outpatient Setting , CDERSafeUseInitiative@fda.hhs.gov http://wcms.fda.gov/FDAgov/Drugs/NewsEvents/ucm538670.htm?SSContributor=true https://www.fda.gov https://www.fda.gov/AboutFDA/WorkingatFDA/BuildingsandFacilities/WhiteOakCampusInformation/ucm241740.htm https://www.regulations.gov Vol. 82, no. 77 Office of the Federal Register, National Archives and Records Administration 2017-04-24 continuing daily deposited born digital 144 p. Table of Contents: AE 2.7: GS 4.107: AE 2.106: KF70.A2 https://www.govinfo.gov/app/details/FR-2017-04-24 P0b002ee194a6f9ad 0097-6326 0042-1219 0364-1406 769-004-00000-9 000582072 f:fr24ap17 https://www.govinfo.gov/app/details/FR-2017-04-24 https://www.govinfo.gov/content/pkg/FR-2017-04-24/pdf/FR-2017-04-24.pdf https://www.govinfo.gov/content/pkg/FR-2017-04-24/xml/FR-2017-04-24.xml fdlp 18841 18974 DGPO 2017-04-22 2024-06-01 FR-2017-04-24 machine generated eng FR FR-2017-04-24 82 77